Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats

Food and Chemical Toxicology

Volumn 46, Issue 5, 2008, Pages 1771-1777

  Yen, Feng Lin ^a   Wu, Tzu Hui ^a   Lin, Liang Tzung ^b   Cham, Thau Ming ^a   Lin, Chun Ching ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antioxidant; Cuscuta chinensis; Hepatoprotective; Nanoparticles

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CUSCUTA CHINENSIS EXTRACT; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NANOPARTICLE; PARACETAMOL; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHINESE MEDICINE; CONTROLLED STUDY; CUSCUTA CHINENSIS; DRUG DOSE COMPARISON; DRUG FORMULATION; DRUG SOLUBILITY; LIVER BIOPSY; LIVER PROTECTION; LIVER TOXICITY; MALE; MEDICINAL PLANT; NONHUMAN; RAT; TREATMENT OUTCOME;

ACETAMINOPHEN; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CATALASE; CHEMISTRY, PHARMACEUTICAL; CUSCUTA; GLUTATHIONE PEROXIDASE; HEPATITIS, TOXIC; LIPID PEROXIDATION; LIVER; LIVER FUNCTION TESTS; MALE; MALONDIALDEHYDE; NANOPARTICLES; OXIDATIVE STRESS; PARTICLE SIZE; PLANT EXTRACTS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

CUSCUTA CHINENSIS; RATTUS;

EID: 40849101564     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.01.021     Document Type: Article

References (43)

1. Aebi H. Catalase in vitro. Methods in Enzymology 105 (1984) 121-126
2. Allémann E., Gurny R., and Doelker E. Drug loaded nanoparticles: preparation methods and drug targeting issues. European Journal of Pharmaceutics and Biopharmaceutics 39 (1993) 173-191
3. Arica Yegin B., Benoit J.P., and Lamprecht A. Paclitaxel-loaded lipid nanoparticles prepared by solvent injection or ultrasound emulsification. Drug Development and Industrial Pharmacy 32 (2006) 1089-1094
4. Bao X., Wang Z., Fang J., and Li X. Structural features of an immunostimulating and antioxidant acidic polysaccharide from the seeds of Cuscuta chinensis. Planta Medica 68 (2002) 237-243
5. Beauchamp C., and Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Analytical Biochemistry 44 (1971) 276-287
6. Bessems J.G., and Vermeulen N.P. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Critical Reviews in Toxicology 31 (2001) 55-138
7. Brigger I., Dubernet C., and Couvreur P. Nanoparticles in cancer therapy and diagnosis. Advanced Drug Delivery Reviews 54 (2002) 631-651
8. Chen Y., Zhang G.G., Neilly J., Marsh K., Mawhinney D., and Sanzgiri Y.D. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. International Journal of Pharmaceutics 286 (2004) 69-80
9. Chen Y., Liu J., Yang X., Zhao X., and Xu H. Oleanolic acid nanosuspensions: preparation, in vitro characterization and enhanced hepatoprotective effect. The Journal of Pharmacy and Pharmacology 57 (2005) 259-264
10. Cornwell T., Cohick W., and Raskin I. Dietary phytoestrogens and health. Phytochemistry 65 (2004) 995-1016
11. Dahlin D.C., Miwa G.T., Lu A.Y.H., and Nelson S.D. N-acetyl-p-benzoquinone imine: a cytochrome P-450 mediated oxidation product of acetaminophen. Biochemistry 81 (1984) 1327-1331
12. Davidson D.G., and Eastham W.N. Acute liver necrosis following overdose of paracetamol. British Medical Journal 2 (1966) 497-499
13. Flohe L., and Gunzler W.A. Assays of glutathione peroxidase. Methods in Enzymology 105 (1984) 114-121
14. Hinson J.A., Bucci A.R., Irwin L.K., Michael S.L., and Mayeux P.R. Effect of inhibitors of nitric oxide synthase on acetaminophen-induced hepatotoxicity in mice. Nitric Oxide 6 (2002) 160-167
15. Hinson J.A., Reid A.B., McCullough S.S., and James L.P. Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metabolism Reviews 36 (2004) 805-822
16. Jaeschke H., Knight T.R., and Bajt M.L. The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. Toxicology Letters 144 (2003) 279-288
17. James L.P., Mayeux P.R., and Hinson J.A. Acetaminophen-induced hepatotoxicity. Drug Metabolism and Disposition 31 (2003) 1499-1506
18. Lin C.C., Tsai C.C., and Yen M.H. The evaluation of hepatoprotective effects of Taiwan folk medicine 'Teng-Khia-U'. Journal of Ethnopharmacology 45 (1995) 113-123
19. Liu J.H., Jiang B., Bao Y.M., and An L.J. Effect of Cuscuta chinensis glycoside on the neuronal differentiation of rat pheochromocytoma PC12 cells. International Journal of Developmental Neuroscience 21 (2003) 277-281
20. Liversidge E.M., Liversidge G.G., and Cooper E.R. Nanosizing: a formulation approach for poorly-water-soluble compounds. European Journal of Pharmaceutical Sciences 18 (2003) 113-120
21. Liversidge G.G., and Cundy K.C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. International Journal of Pharmaceutics 125 (1995) 91-97
22. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry 193 (1951) 265-275
23. Mainardes R.M., and Evangelista R.C. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. International Journal of Pharmaceutics 290 (2005) 137-144
24. Memisoglu-Bilensoy E., Dogan A.L., and Hincal A.A. Cytotoxic evaluation of injectable cyclodextrin nanoparticles. The Journal of Pharmacy and Pharmacology 58 (2006) 585-589
25. Michael S.L., Pumford N.R., Mayeux P.R., Niesman M.R., and Hinson J.A. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 30 (1999) 186-195
26. Miner D.J., and Kissinger P.T. Evidence for the involvement of NABQI in acetaminophen metabolism. Biochemical Pharmacology 28 (1979) 3285-3290
27. Mitchell J.R., Jollow D.J., Potter W.Z., Gillette J.R., and Brodie B.B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. The Journal of Pharmacology and Experimental Therapeutics 187 (1973) 211-217
28. Müller R.H., and Peters K. Nanosuspensions for the formulation of poorly soluble drugs: preparation by a sizereduced technique. International Journal of Pharmaceutics 160 (1998) 229-237
29. Nisa M., Akbar S., Tariq M., and Hussain Z. Effect of Cuscuta chinensis water extract on 7, 12-dimethylbenz [a] anthracene-induced skin papillomas and carcinomas in mice. Journal of Ethnopharmacology 18 (1986) 21-31
30. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95 (1979) 351-358
31. Ratnam D.V., Ankola D.D., Bhardwaj V., Sahana D.K., and Kumar M.N. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. Journal of Controlled Release 113 (2006) 189-207
32. Shah T.J., Amin A.F., Parikh J.R., and Parikh R.H. Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug. AAPS Pharm Sci Tech 8 (2007) E1-E7 (Article 29)
33. Singh S., and Muthu M.S. Preparation and characterization of nanoparticles containing an atypical antipsychotic agent. Nanomedicine 2 (2007) 233-240
34. Sonaje K., Italia J.L., Sharma G., Bhardwaj V., Tikoo K., and Kumar M.N. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Pharmaceutical Research 24 (2007) 899-908
35. Tiyaboonchai W., Tungpradit W., and Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. International Journal of Pharmaceutics 337 (2007) 299-306
36. Umehara K., Nemoto K., Ohkubo T., Miyase T., Degawa M., and Noguchi H. Isolation of a new 15-membered macrocyclic glycolipid lactone, Cuscutic Resinoside a from the seeds of Cuscuta chinensis: a stimulator of breast cancer cell proliferation. Planta Medica 70 (2004) 299-304
37. Williamson G., Barron D., Shimoi K., and Terao J. In vitro biological properties of flavonoid conjugates found in vivo. Free Radical Research 39 (2005) 457-469
38. Wu T.H., Yen F.L., Lin L.T., Tsai T.R., Lin C.C., and Cham T.M. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. International Journal of Pharmaceutics 346 (2008) 160-168
39. Yang C.X., Xu X.H., and Dong Y. Advances in the research on targeted preparations of traditional Chinese medicine and natural drugs. Zhongguo Zhong Yao Za Zhi 28 (2003) 696-700
40. Ye M., Yan Y., and Guo D.A. Characterization of phenolic compounds in the Chinese herbal drug Tu-Si-Zi by liquid chromatography coupled to electrospray ionization mass spectrometry. Rapid Communications in Mass Spectrometry 19 (2005) 1469-1484
41. Yen F.L., Wu T.H., Lin L.T., and Lin C.C. Hepatoprotective and antioxidant effects of Cuscuta chinensis against acetaminophen-induced hepatotoxicity in rats. Journal of Ethnopharmacology 111 (2007) 123-128
42. Zheng H.Z., Dong Z.H., and She J. Modern study of traditional Chinese medicine. first ed. (1998), Beijing Xue Yuan Press, People's Republic of China, Beijing pp. 4110-4120
43. Zweers M.L., Grijpma D.W., Engbers G.H., and Feijen J. The preparation of monodisperse biodegradable polyester nanoparticles with a controlled size. Journal of Biomedical Materials Research. Part B, Applied Biomaterials 66 (2003) 559-566